ClinicalTrials.gg
Drug

Migalastat clinical trials

Also written Galafold, Lucerastat, OGT-923 and ACT-434964.

studies test it
24
open now
2
in phase 3
11
first study started
2002

How each study uses migalastat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the migalastat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Aug 2018 · GALAFOLD · NDA 208623 (FDA, Drugs@FDA)
European Union
25 May 2016 · Galafold · EMEA/H/C/004059 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

AT1001
15
migalastat
11
migalastat HCl
6
migalastat HCl 150 mg
4
migalastat hydrochloride
3

Brand

Galafold
12

Development codes

OGT-923
2
ACT-434964
2
CDP923
1

Other names

Lucerastat
6

Studies by the year they started

24 studies that test it; most in 2011 (5)

Studies that test migalastat, by start year
YearStudies
20021
20031
20064
20071
20091
20115
20141
20151
20184
20192
20221
20262

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
6
Phase 3
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 0

Amicus Therapeutics (17) · Idorsia Pharmaceuticals Ltd. (7)

Often tested with

Tested in the same studies.

Larazotide acetate (1) · Larazotide (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Migalastat is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test migalastat, phase 3 first.

Studies

Open first, then newest update. How each study uses migalastat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 24

See all 24 studies that test migalastat →

Given beside what is tested · 1 — migalastat is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with migalastat

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call migalastat · ClinicalTrials.gg INT003808

  • MeSH (NLM) C090092migalastatConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) C4XNY919FWMIGALASTATConfirmed FDA, NLM, Wikidata
  • RxNorm 2054252Confirmed FDA, Wikidata
  • Wikidata Q161613migalastatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C78120MigalastatOne source FDA
  • DrugBank DB05018One source Wikidata

Also registered as lucerastat (UNII GVS3YDM418) and migalastat hydrochloride (UNII CLY7M0XD20 · RxNorm 2054264).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.